CHE Stock Analysis: Buy, Sell, or Hold?
CHE - Chemed Corporation
$444.11
8.04 (1.84%)
▲
5d:
+4.87%
30d:
+0.58%
90d:
+18.93%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When CHE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CHE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CHE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$617.90
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$383.67
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CHE is currently trading at $444.11, which is considered extended relative to its 30-day fair value range of $426.29 to $442.36. The stock's valuation (Forward PE: 16.5) is in line with its historical norms (16.2). At these levels, the market is pricing in 0.5% annual earnings growth.
Technical Outlook: Technically, CHE is showing sideways momentum. The price is approaching resistance at $450.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CHE is showing sideways momentum. The price is approaching resistance at $450.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$426.29 -
$442.36
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
49.5%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($446.50)
- BULLISH: Expecting earnings turnaround to 0.5% growth with 1.6% revenue growth
Trading Range Analysis
30-Day Trading Range
$426.29 -
$442.36
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$411.02
Resistance Level
$450.00
Current Trend
Sideways
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.50
Wall Street Target
$446.50
(+0.5%)
Revenue Growth (YoY)
1.6%
Earnings Growth (YoY)
-0.4%
Profit Margin
10.2%
Valuation Premium vs History
+0.5% premium
PE vs Historical
16.5 vs 16.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.5%
(market-implied from PE analysis)
1-Year Target
$446.33
(+1%)
2-Year Target
$448.56
(+1%)
3-Year Target
$450.81
(+2%)
3-Yr Target (if PE normalizes)
(PE: 17→16)
PE COMPRESSION
$442.51
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.5%)
$790.83
(+78%)
Base:
(SPY PE: 16.5, Growth: 10.5%)
$599.24
(+35%)
Bear:
(PE: 14.0, Growth: 10.5%)
$509.35
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 23.82 | Current EPS (TTM): $18.31
Bull Case
$704.97
(+59%)
Analyst growth 47.0%, PE expands to 26.2
Base Case
$640.89
(+44%)
Market implied 47.0%, PE stable at 23.8
Bear Case
$296.53
(-33%)
Severe decline -20.0%, PE contracts to 20.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 7:37 PM ET
Data refreshes hourly during market hours. Next update: 8:37 PM
Data refreshes hourly during market hours. Next update: 8:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CHE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin J Mcnamara
SELL
2000 shares
2026-03-12
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 58 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 53 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 60 HOLD |